Engitix Therapeutics
PrivateLast Round
Series A
Extension
Jan 8, 2026
Total Funding Raised
$85.4M
Company Overview
Engitix Therapeutics is a biotechnology company that develops therapies for cancer and fibrosis by targeting the extracellular matrix (ECM).
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Healthcare Analytics, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Engitix Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Engitix Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jan 8, 2026 | ||||
| Series A | Jan 19, 2022 | ||||
| Seed | Nov 27, 2018 |
Key People
Founding team and executive leadership
Engitix Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Netherton Investments | Seed, Series A, Series A Extension |
| UCL Business | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 8, 2026
Raised $25M in Series A Extension funding.
Engitix Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Engitix Therapeutics's valuation, stock price, and market status.
